Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.14 is 168% above its 1-year average of 0.05, near the high end of its 1-year range (-0.11–0.14).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.14.
DEBT TO EQUITY RATIO
0.14
DEBT TO EQUITY RATIO AVG TTM
N/A
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.14
median of 513 covered companies
CURRENT VS SECTOR MEDIAN
-1.91%
vs the sector median at left
Generate Biomedicines, Inc.
Market Cap
$1.75B
Debt to Equity Ratio
0.14
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Debt to Equity Ratio
0.10
TTM Avg
0.19
3Y Avg
0.15
5Y Avg
0.12
Market Cap
$1.73B
Debt to Equity Ratio
1.71
TTM Avg
1.50
3Y Avg
1.07
5Y Avg
0.87
Market Cap
$1.71B
Debt to Equity Ratio
1.25
TTM Avg
2.57
3Y Avg
1.73
5Y Avg
2.08
Market Cap
$1.83B
Debt to Equity Ratio
0.45
TTM Avg
0.51
3Y Avg
0.29
5Y Avg
0.25
Market Cap
$1.83B
Debt to Equity Ratio
1.18
TTM Avg
1.02
3Y Avg
0.74
5Y Avg
0.70
Market Cap
$1.85B
Debt to Equity Ratio
0.03
TTM Avg
0.04
3Y Avg
0.06
5Y Avg
0.10
Market Cap
$1.63B
Debt to Equity Ratio
N/A
TTM Avg
40.93
3Y Avg
29.06
5Y Avg
18.39
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.75B | 0.14 | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | 0.10 | 0.19 | 0.15 | 0.12 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 1.71 | 1.50 | 1.07 | 0.87 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.71B | 1.25 | 2.57 | 1.73 | 2.08 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.83B | 0.45 | 0.51 | 0.29 | 0.25 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.18 | 1.02 | 0.74 | 0.70 |
| Absci Corporation (ABSI)vs › | $1.80B | 0.01 | 0.04 | 0.07 | 0.09 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.85B | 0.03 | 0.04 | 0.06 | 0.10 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.63B | N/A | 40.93 | 29.06 | 18.39 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 0.55 | 1.03 | 0.88 | 0.88 |
Debt/Equity
0.14
Current Ratio
8.30
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.14 |
| 2026-03-31 | 0.13 |
| 2025-12-31 | -0.11 |
